These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 34906409)

  • 1. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
    Raj S; Ogola G; Han J
    Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
    Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
    AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency and Characteristics of Nodal and Deltoid FDG and
    Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
    [No Abstract]   [Full Text] [Related]  

  • 4. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.
    Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K
    AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774
    [No Abstract]   [Full Text] [Related]  

  • 5. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women.
    Marcon M; Catanese C; Scarano AL; Del Grande F; Manganiello M; Palermo M; Rizzo S
    Radiol Med; 2023 Oct; 128(10):1217-1224. PubMed ID: 37626156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
    Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
    Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA
    Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.
    Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
    Clin Imaging; 2021 Jul; 75():12-15. PubMed ID: 33486146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
    Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M
    Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up.
    Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
    Clin Imaging; 2021 Dec; 80():83-87. PubMed ID: 34298342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
    Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
    Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Timing, and Long-Term Outcomes of COVID-19 Vaccine-Related Lymphadenopathy on Screening Mammography.
    Lamb LR; Mercaldo SF; Carney A; Leyva A; D'Alessandro HA; Lehman CD
    J Am Coll Radiol; 2024 Sep; 21(9):1477-1488. PubMed ID: 38461917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
    Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
    Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
    Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
    Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.
    Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J
    Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
    Garreffa E; Hamad A; O'Sullivan CC; Hazim AZ; York J; Puri S; Turnbull A; Robertson JF; Goetz MP
    Eur J Cancer; 2021 Dec; 159():38-51. PubMed ID: 34731748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.